Sweden· SE-20100310000012
Amorolfine Pierre Fabre 5 % Medicinskt nagellack
A amorolfine product, registered in Sweden by Pierre Fabre Dermatologie. The same ATC class is registered in 15 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Amorolfine is registered in 15 of 19 countries.
Countries holding a registration under ATC D01AE16 (amorolfine), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 9 of them publish a price we can compare per daily dose
Amorolfine · ATC D01AE16
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Swedish Medical Products Agency (Sweden)- Manufacturer
- Pierre Fabre Dermatologie
- Country
- Sweden (SE)
- ATC code
- D01AE16
- ATC class
- Amorolfine
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- August 27, 2026
Packs & prices · 1
- se_varunummer20100310000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D01AE16
Amorolfine, as other registers publish it.
- GermanyAmofinGalenpharma Gmbh
- GermanyAmorocutanDermapharm Ag
- PolandAmorolakSun-Farm Sp. z o.o.
- GermanyAmorolfinDermapharm Ag
- SwedenAmorolfin ABECE 5 % Medicinskt nagellackEvolan Pharma AB
- GermanyAmorolfin AcisAcis Arzneimittel Gmbh
- GermanyAmorolfin AcisMibe Gmbh Arzneimittel
- GermanyAmorolfin AdgcZentiva Pharma Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0d01a71e-acec-4186-9736-bd14c187b912 GET /v1/drugs/0d01a71e-acec-4186-9736-bd14c187b912?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR"
],
"se_npl_id": "20100310000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100310000012",
"product_doc_link": "https://docetp.mpa.se/LMF/Amorolfine%20Pierre%20Fabre%20medicated%20nail%20laquer%20ENG%20PAR_09001bee807a2ac2.pdf"
}See everything about amorolfine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.